{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P04626",
      "entity_text" : "HER2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0572" ]
    }
  },
  "verbose_text" : "In a more recent study, they determined HER2 levels by IHC in two cohorts of 10 and 19 breast cancer samples, but a correlation between IHC and SRM data was observed only in the first cohort, suggesting to the authors that many patients with a 3+ IHC staining for HER2 probably do not express elevated levels of this protein and are therefore unlikely to benefit from trastuzumab XREF_BIBR.",
  "reading_complete" : "2020-08-08T16:25:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T16:23:25Z",
  "trigger" : "levels",
  "evidence" : [ "HER2 levels" ],
  "pmc_id" : "4265304",
  "score" : 0
}